2,356
Views
5
CrossRef citations to date
0
Altmetric
Articles

Decreasing lncRNA PVT1 causes Treg/Th17 imbalance via NOTCH signaling in immune thrombocytopenia

, , &

References

  • Swinkels M, Rijkers M, Voorberg J, et al. Emerging concepts in immune thrombocytopenia. Front Immunol. 2018;9:880.
  • Lv Y, Ruan G, Liu Y, et al. Aberrant expression of NLRP3, NLRC4 and NLRP6 inflammasomes in patients with primary immune thrombocytopenia. Thromb Res. 2019;176:101–103.
  • Yazdanbakhsh K, Zhong H, Bao WJ. Immune dysregulation in immune thrombocytopenia. Semin Hematol. 2013, 50 Suppl 1(0 1): S63–S67.
  • Wang Q, Li J, Yu T, et al. Disrupted balance of CD4 T-cell subsets in bone marrow of patients with primary immune thrombocytopenia. Int J Biol Sci. 2019;15(13):2798–2814.
  • Kawaguchi K, Kaneko S. Notch signaling and liver cancer. Notch Signaling in Embryology and Cancer. 2021;1287:69–80.
  • Yin X, Wei H, Wu S, et al. DAPT reverses the Th17/Treg imbalance in experimental autoimmune uveitis in vitro via inhibiting notch signaling pathway. Int Immunopharmacol. 2020;79:106107.
  • Ito T, Schaller M, Hogaboam C, et al. TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived notch ligand delta-like 4. J Clin Invest. 2009;119(1):33–46.
  • Gawdat R, Hammam A, Ezzat DJ. Correlation of Notch1/Hes1 genes expression levels in Egyptian paediatric patients with newly diagnosed and persistent primary immune(idiopathic) thrombocytopenic purpura. Indian Journal of Hematology and Blood Transfusion. 2016;32(3):362–367.
  • Ghetti M, Vannini I, Storlazzi C, et al. Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin. Mol Cancer. 2020;19(1):69.
  • Eftekharian M, Ghafouri-Fard S, Soudyab M, et al. Expression analysis of Long Non-coding RNAs in the blood of multiple sclerosis patients. J Mol Neurosci. 2017;63:333–341.
  • Wu L, Xia J, Li D, et al. Mechanisms of M2 macrophage-derived exosomal Long Non-coding RNA PVT1 in regulating Th17 cell response in experimental autoimmune encephalomyelitisa. Front Immunol. 2020;11:1934.
  • Xu K, Xu Q, Wu Z, et al. LncRNA NEAT1 is involved in temozolomide resistance by regulating MGMT in glioblastoma multiforme. Clin Surg Res Commun. 2018;1:24–30.
  • Wang L, Yang J, Wang H, et al. Highly expressed ribosomal protein L34 predicts poor prognosis in acute myeloid leukemia and could be a poential therapy target. APT. 2020;2:32–37.
  • Roman MG, Flores LC, Cunningham GM, et al. Thioredoxin overexpression in mitochondria showed minimum effects on aging and age-related diseases in male C57BL/6 mice. APT. 2020;2:20–31.
  • Moulis G, Lapeyre-Mestre M, Adoue D, et al. [Epidemiology and pharmacoepidemiology of immune thrombocytopenia]. Rev Med Interne. 2017;38(7):444–449.
  • Lin X, Xu A, Zhou L, et al. Imbalance of T Lymphocyte subsets in adult immune thrombocytopenia. Int J Gen Med. 2021;14:937–947.
  • Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235–238.
  • Tang Z, Wang Y, Xing R, et al. Deltex-1 is indispensible for the IL-6 and TGF-β treatment-triggered differentiation of Th17 cells. Cell Immunol. 2020;356:104176.
  • Cheng L, Liu C, Li F, et al. The prediction value of Treg cell subtype alterations for glucocorticoid treatment in newly diagnosed primary immune thrombocytopenia patients. Thromb Res. 2019;181:10–16.
  • Feng Y, Xiao Y, Yan H, et al. Sirolimus as rescue therapy for refractory/relapsed immune thrombocytopenia: results of a single-center, prospective, single-Arm study. Front Med (Lausanne). 2020;7:110.
  • Li J, Tian J, Lu J, et al. LncRNA GAS5 inhibits Th17 differentiation and alleviates immune thrombocytopenia via promoting the ubiquitination of STAT3. Int Immunopharmacol. 2020;80:106127.
  • Li J, Xia Y, Fan X, et al. Extracellular vesicles derived from miR-199a-5p-modified adipose-derived mesenchymal stem cells alleviate immune thrombocytopenia by inhibiting T helper 17 differentiation. Lab Invest. 2021;101(3):318–327.
  • Li T, Gu M, Liu P, et al. Abnormal expression of Long noncoding RNAs in primary immune thrombocytopenia: A microarray related study. Cell Physiol Biochem. 2018;48(2):618–632.
  • Ayoub S, Hefzy E, Abd El-Hmid R, et al. Analysis of the expression profile of long non-coding RNAs MALAT1 and THRIL in children with immune thrombocytopenia. IUBMB Life. 2020;72(9):1941–1950.
  • Li J, Hu S, Wang Z, et al. Long non-coding RNA MEG3 inhibits microRNA-125a-5p expression and induces immune imbalance of treg/Th17 in immune thrombocytopenic purpura. Biomed Pharmacother. 2016;83:905–911.
  • Fu J, Shi H, Wang B, et al. LncRNA PVT1 links Myc to glycolytic metabolism upon CD4 T cell activation and sjögren's syndrome-like autoimmune response. J Autoimmun. 2020;107:102358.
  • Amsen D, Helbig C, Backer RJ. Notch in T cell differentiation: All things considered. Trends Immunol. 2015;36(12):802–814.
  • Siebel C, Lendahl U. Notch signaling in development, tissue homeostasis, and disease. Physiol Rev. 2017;97(4):1235–1294.
  • Qin L, Zhou Y, Wu H, et al. Notch signaling modulates the balance of regulatory T cells and T helper 17 cells in patients with chronic hepatitis C. DNA Cell Biol. 2017;36(4):311–320.
  • Jiao W, Wei J, Kong Y, et al. Notch signaling promotes development of allergic rhinitis by suppressing Foxp3 expression and Treg cell differentiation. Int Arch Allergy Immunol. 2019;178(1):33–44.
  • Ma D, Dai J, Zhu X, et al. Aberrant expression of notch signaling molecules in patients with immune thrombocytopenic purpura. Scand J Clin Lab Invest. 2010;89(2):155–161.
  • Yu S, Liu C, Li L, et al. Inactivation of notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia. Lab Invest. 2015;95(2):157–167.